THE EFFECT OF CHLORMADINONE ON THE RESPONSE OF THE OVARIES AND UTERUS OF THE IMMATURE RAT TO GONADOTROPHIC STIMULATION

1964 ◽  
Vol 30 (2) ◽  
pp. 235-245 ◽  
Author(s):  
M. J. K. HARPER

SUMMARY The effects of chlormadinone (6-chloro-Δ6-17α-acetoxyprogesterone), an orally active progestational agent without significant oestrogenic activity, on the response of the ovaries of intact and hypophysectomized immature female rats to exogenous gonadotrophin have been examined. Administration of the steroid whether starting on the same day as, or 4 days before treatment with gonadotrophin, did not depress the ovarian response in intact rats. In hypophysectomized animals, pretreated with the progestagen, the ovarian response to gonadotrophin was depressed. In intact rats, treatment with the steroid and pregnant mare serum gonadotrophin (PMSG) resulted in ovulation, whereas in similar animals given PMSG alone no corpora lutea were found. Corpora lutea were seen in all groups given PMSG and human chorionic gonadotrophin (HCG) but ovulation occurred earlier when, in addition, treatment with the steroid was included. In only one experiment with intact rats did administration of the steroid alone cause a significant increase in uterine weight compared with controls. In neither experiment on hypophysectomized animals did such an increase occur, and significant decreases were recorded.

1972 ◽  
Vol 55 (3) ◽  
pp. 533-541 ◽  
Author(s):  
J. Th. J. UILENBROEK ◽  
J. J. van der WERFF ten BOSCH

SUMMARY Ovulation-inducing effects of pregnant mare serum gonadotrophin (PMSG) were studied in immature female rats treated on day 5 (day 1 = day of birth) with oil or with 5 or 1250 μg testosterone propionate (TP). The response of rats treated with 1250 μg TP was negligible regardless of the age of the animals and of the dose of PMSG. The response of rats treated with 5 μg TP to PMSG alone was low (36% of rats, with 2·6 ova/ovulating rat), but could be improved by progesterone administration 2 days after PMSG injection (91% of rats, with 14·5 ova/ovulating rat). At every age and dose of PMSG tested the response of animals treated with 5 μg TP to combined PMSG and progesterone treatment was less than that of control animals. It is concluded that neonatal TP treatment diminishes the release of endogenous ovulating hormone subsequent to PMSG injection. This effect is dependent on the dose of TP used, but already demonstrable in animals treated with 5 μg TP on day 5, which would have been cyclic and fertile after puberty. Only for the animals treated with 1250 μg TP could a decreased sensitivity of the ovaries to combined administration of PMSG and human chorionic gonadotrophin be demonstrated.


1963 ◽  
Vol 204 (6) ◽  
pp. 1023-1027 ◽  
Author(s):  
B. D. Smith ◽  
J. T. Bradbury

Hypophysectomized or intact immature female rats were given follicle-stimulating hormone (FSH), pregnant mare's serum gonadotrophin (PMS), human chorionic gonadotrophin (HCG), or luteinizing hormone (LH) for 3 days, with or without prior administration of diethylstilbestrol for 2 days. Priming with estrogen augmented the ovarian weight response produced by FSH or PMS in both hypophysectomized and intact animals. In contrast, estrogen pretreatment enhanced ovarian growth in intact rats given HCG or LH, but not in hypophysectomized animals similarly treated. Longer periods of priming also failed to augment the ovarian response to HCG in hypophysectomized rats. The ovaries of intact rats given diethylstilbestrol and FSH contained many corpora lutea, whereas luteinization was never noted in hypophysectomized animals similarly treated. Ovarian weight augmentation in the latter was due to enhanced follicular growth throughout the ovary. Estrogen and HCG produced cystic, luteinized follicles in intact rats, in contrast to the lack of such follicular stimulation in hypophysectomized animals. It is concluded that estrogen increases the ovarian response to gonadotrophins by 1) directly stimulating granulosal proliferation, and 2) effecting the release of endogenous gonadotrophins from the pituitary gland.


1965 ◽  
Vol 33 (3) ◽  
pp. 447-454
Author(s):  
M. J. K. HARPER

SUMMARY Administration of chlormadinone, an orally active progestational agent without significant oestrogenic activity, to intact immature female rats did not affect either ovarian or uterine weight significantly compared with controls. A single injection of human chorionic gonadotrophin (HCG) caused a 73 % increase in uterine weight in 24 hr. over the control value. This dose significantly increased ovarian weight and although it caused some stimulation of follicular development, ovulation during this time did not occur. When animals were treated with chlormadinone for 8 days, and received HCG on the 8th day, uterine weight was 170% greater than in the controls and 56% greater than with HCG alone. The uterine weight produced was similar to that found in animals treated with mestranol, a potent oestrogen, and HCG. In ovariectomized animals HCG did not affect uterine weight, while the small increase produced by chlormadinone was unaltered when HCG also was given. Mechanisms are discussed by which this augmentation of the uterine response to HCG might be produced. It seems most likely that chlormadinone administration causes storage of endogenous gonadotrophin in the pituitary, and that the exogenous gonadotrophin acts as the 'trigger' for the release of stored hormone, probably by a direct action on the hypothalamus.


1983 ◽  
Vol 103 (3) ◽  
pp. 406-412 ◽  
Author(s):  
Kalle Jääkeläinen ◽  
Seppo Markkanen ◽  
Hannu Rajaniemi

Abstract. The subcellular distribution of 125I-labelled human chorionic gonadotrophin (hCG) in preovulatory rat granulosa cells was studied in vivo. Pregnant mare serum gonadotrophin-pretreated immature female rats received an iv injection of [125I]hCG a few hours before the endogenous preovulatory gonadotrophin surge. The animals were killed at 2 or 6 h after the [125I]hCG injections. Light microscope autoradiographs showed that the mural granulosa cells of large follicles were the most highly labelled cells in the ovaries. Electron microscope autoradiography was used to study the subcellular distribution of radioactivity in the mural granulosa cells. At 2 h 45% of the counted silver grains were associated with the plasma membrane and 10% with the lysosomes, at 6 h the values were 51% and 9%, respectively. The distribution of the observed silver grains was compared with the generated expected source to grain pairs by computerized linear multiple regression analysis. The magnitudes of the regression coefficients revealed that the plasma membrane and the lysosomes were the only specifically 125I-labelled organelles, that a few radioactive molecules were located diffusely over the cytoplasm at 2 h and that the 125I-radioactivity of the nuclei was negligible. The present results suggest that preovulatory rat granulosa cells are in vivo able to internalize into lysosomes [125I]hCG initially bound to LH/hCG receptors of the plasma membrane.


1954 ◽  
Vol 11 (4) ◽  
pp. 359-376 ◽  
Author(s):  
ANITA M. MANDL

SUMMARY The sensitivity of adrenalectomized, control-operated and unoperated rats to pregnant mare serum (PMS) and chorionic gonadotrophin (CG) has been studied. A total of 638 mature and immature female rats was used. The ovaries of adrenalectomized rats were found to contain fewer large follicles and corpora lutea than those of control-operated litter-mates, and the slight ovarian hypertrophy which occurs after surgical trauma was found to be due to an increase in the number of Graafian follicles and corpora lutea. Further experiment showed that, as judged by the weight of the ovaries, adrenalectomy reduces the ovarian reaction to injected PMS (10 i.u./day) in both adult and immature rats. Replacement therapy with DCA (1 mg/day) failed to re-establish the normal response in adults. Treatment with cortisone (1 mg/day) restored the normal reaction in both adult and immature adrenalectomized rats. Adrenalectomized adult rats responded to injected CG (10 i.u./day) as vigorously as their operated and unoperated litter-mates. On the other hand, immature adrenalectomized animals did not respond fully to CG. Treatment with cortisone again fully restored the normal reaction.


1960 ◽  
Vol XXXIV (II) ◽  
pp. 176-188 ◽  
Author(s):  
A. Hasselblatt ◽  
Ch. Ratabongs

ABSTRACT The effect of pregnant mare serum gonadotrophin (PMS) and human chorionic gonadotrophin (HCG) on the thyroid gland of normal, of gonadectomized and of hypophysectomized infantile rats has been studied. Gonadotrophin treatment stimulated the thyroid of normal and hypophysectomized female rats. A corresponding effect was not observed in gonadectomized female or in normal and gonadectomized male rats. These results show that the gonadotrophic hormones stimulate thyroid function indirectly by increasing the hormonal secretion of the ovaries. An intimate functional relationship between the ovaries and the thyroid gland was thus demonstrated. As the stimulating effect of gonadotrophin treatment was also present in hypophysectomized female rats, it was concluded that the oestrogens act directly on the thyroid gland. Their thyrotrophic action is not mediated by the pituitary gland.


1969 ◽  
Vol 60 (1) ◽  
pp. 137-156 ◽  
Author(s):  
C. Robyn ◽  
P. Petrusz ◽  
E. Diczfalusy

ABSTRACT The follicle stimulating hormone (FSH)-like activity of human chorionic gonadotrophin (HCG) preparations was assayed by the method based on the ovarian weight augmentation in intact immature rats. The potencies ranged from 4.8 to 7.4 IU equivalents of FSH per mg. The FSH-like potency of the Second International Standard Preparation of HCG was 8.5 IU per vial. However, when in intact immature rats the ovarian weight response to HCG preparations was compared at a wide range of doses (40 to 51 200 IU) to that obtained with a human menopausal gonadotrophin (HMG) preparation (0.5 to 128 IU of FSH) in the presence of 40 IU of HCG, significant differences were found. The assays conducted in hypophysectomised immature female rats were invalid, because of lack of parallelism. Antisera were prepared by immunising rabbits with HCG and human hypophysial gonadotrophin (HHG) preparations and the antigonadotrophin profiles (HCG-, FSH- and FSH-like neutralising potencies) of these antisera were established by the use of statistically valid bioassay procedures. The anti-HCG and anti-HHG sera neutralised the FSH activity of HMG preparations as well as the FSH-like activity of HCG preparations. However, 3 to 175 times more antiserum was required to neutralise the equivalent of 1.0 IU of FSH-like activity present in HCG than expected on the basis of the anti-FSH potency of the antisera. On the other hand, there was a high degree of correlation between the neutralising potencies of the antisera when tested against the FSH-like activity and the HCG activity of various HCG preparations. When the FSH-like activity of an HCG preparation was quantitatively neutralised with an anti-HCG serum, some 30 per cent of the HCG activity remained unneutralised, as evidenced by repeated bioassays. Although at least 2000 IU of this »FSH-free« HCG was administered to groups of intact as well as hypophysectomised immature female rats, this high dose of HCG did not induce an increase in ovarian weight beyond that elicited by 40 IU of untreated HCG. Histological examination of the ovaries indicated lack of follicle stimulation in the hypophysectomised, but not in the intact immature animals. There was an excessive stimulation of the interstitial cells in both types of animals. The data indicate that the FSH-like activity of HCG preparations is neither due to a contamination by FSH of pituitary origin, nor is it an evenly distributed intrinsic property of the HCG molecules. It is also concluded that the gonadotrophic activity of biologically pure HCG in immature hypophysectomised female rats consists of a specific stimulation of the interstitial cell apparatus. Such HCG preparations do not induce any follicle stimulation, not even when administered in excessive doses.


1970 ◽  
Vol 48 (3) ◽  
pp. 196-199 ◽  
Author(s):  
S. M. Husain ◽  
R. Saucier

Ovulation was induced in mature female rats by appropriately timed injections of pregnant mare serum gonadotrophin (PMSG) and human chorionic gonadotrophin (HCG). Various combinations of the gonadotrophins were used. Maximal ovulatory response was consistently obtained with 50 I.U. PMSG and any combination of HCG between 50 I.U. and 5000 I.U. On the basis of the results obtained it is recommended that 50 I.U. PMSG and 50 I.U. HCG be injected to obtain a maximal ovulatory response in mature rats. High doses of PMSG (but not HCG) suppress ovulation markedly.


1994 ◽  
Vol 140 (3) ◽  
pp. 409-417 ◽  
Author(s):  
S A Ghersevich ◽  
M H Poutanen ◽  
H J Rajaniemi ◽  
R K Vihko

Abstract Antibodies against human placental 17β-hydroxysteroid dehydrogenase (17-HSD) and 17-HSD cDNA were used to study the expression of the corresponding enzyme in the immature rat ovary during follicular development and luteinization, which were induced by treating the animals with pregnant mare serum gonadotrophin (PMSG) or with PMSG followed by human chorionic gonadotrophin (hCG). Immuno-blot analysis indicated that the Mr of the 17-HSD expressed in rat granulosa cells was 35 000, as previously shown for the human placental enzyme. In immunohistochemical studies of untreated immature rat ovaries, only the granulosa cells from small antral follicles were stained. One day after PMSG treatment, strong expression of 17-HSD was observed in the granulosa cells of growing Graafian follicles. A marked decrease in enzyme expression was observed in preovulatory follicles on day 2 of PMSG treatment, starting from the basal layers of granulosa cells and progressing toward the luminal cells. No 17-HSD expression was detected in luteinized follicles or corpora lutea 22 h after hCG injection. The stroma and theca cells were negative for 17-HSD staining. In Northern hybridization analyses, two 17-HSD mRNAs were detected (1·4 and 1·7 kb). The strongest expression for both mRNAs was detected after 1 day of PMSG treatment, coinciding with maximal immunostaining of the enzyme protein. Down-regulation of 17-HSD observed by immunohistochemistry was reflected in a similar decrease in mRNA expression and the signals were almost undetectable 22 h after hCG injection. Our data suggest that 17-HSD expression in rat granulosa cells is up-regulated during follicular development and, thereafter, the enzyme expression is down-regulated during luteinization. Journal of Endocrinology (1994) 140, 409–417


1982 ◽  
Vol 92 (1) ◽  
pp. 43-49 ◽  
Author(s):  
SHIGETAKA ICHIKAWA ◽  
YUKIO NAKAMURA ◽  
TSUTOMU SAWADA

Prepubertal rats, induced to mate by treatment with pregnant mare serum gonadotrophin (sperm present = day 0), were used in all experiments. The reduction in the number of corpora lutea (CL) of pregnancy to four on days 10 or 13 of pregnancy produced placental hypertrophy when compared to sham-operated controls, but a reduction to six had no effect on placental growth. The removal of all primary CL on days 11 or 13 of pregnancy in pregnant rats bearing additional secondary CL induced by an injection of human chorionic gonadotrophin (hCG) on days 5 or 7 of pregnancy also resulted in placental hypertrophy. Ovarian secretion of progesterone on day 13 of pregnancy was significantly lowered after reducing CL to four in normal pregnant rats and removing primary CL from rats treated with hCG on day 5. Removal of primary CL from rats treated with hCG on day 5 had no effect on oestradiol-17β secretion, whereas reducing CL to four in normal pregnant rats significantly increased it. Daily injections of 4 mg progesterone until day 17 of pregnancy from the day of reduction of the number of CL, or from the day of removal of primary CL, prevented placental hypertrophy. These results suggest that the decrease of progesterone, but not of oestrogen, is the main factor inducing placental hypertrophy in ovariectomized pregnant rats.


Sign in / Sign up

Export Citation Format

Share Document